MedTrace Logo

Drug-Eluting Stent Implantation Versus Optimal Medical Treatment in Patients With Chronic Total Occlusion (DECISION-CTO)

NCT01078051 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 840

Last updated 2019-08-02

No results posted yet for this study

Summary

The purpose of this study is to compare the safety and effectiveness of drug-eluting stent implantation compared to optimal medical treatment in patients with chronic total occlusion.

Conditions

Interventions

PROCEDURE

Cypher, xience, Endeavor, Taxus

all species of drug-eluting stent implantation

DRUG

optimal medical therapy

optimal medical therapy

Sponsors & Collaborators

  • CardioVascular Research Foundation, Korea

    collaborator OTHER

  • Seung-Jung Park

    lead OTHER

Principal Investigators

  • Seung-Jung Park, MD,PhD · Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-22
Primary Completion
2019-07-22
Completion
2019-07-22

Countries

  • India
  • Indonesia
  • South Korea
  • Taiwan
  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01078051 on ClinicalTrials.gov